<code id='018E6866A8'></code><style id='018E6866A8'></style>
    • <acronym id='018E6866A8'></acronym>
      <center id='018E6866A8'><center id='018E6866A8'><tfoot id='018E6866A8'></tfoot></center><abbr id='018E6866A8'><dir id='018E6866A8'><tfoot id='018E6866A8'></tfoot><noframes id='018E6866A8'>

    • <optgroup id='018E6866A8'><strike id='018E6866A8'><sup id='018E6866A8'></sup></strike><code id='018E6866A8'></code></optgroup>
        1. <b id='018E6866A8'><label id='018E6866A8'><select id='018E6866A8'><dt id='018E6866A8'><span id='018E6866A8'></span></dt></select></label></b><u id='018E6866A8'></u>
          <i id='018E6866A8'><strike id='018E6866A8'><tt id='018E6866A8'><pre id='018E6866A8'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:33
          Sen. Elizabeth Warren gestures with one hand during a hearing — insurance coverage from STAT
          Sen. Elizabeth Warren (D-Mass.) Kent Nishimura/Getty Images

          Senate Democrats on Thursday said Medicare should take more urgent and aggressive action to prevent health insurance companies from using artificial intelligence to unlawfully deny medical services.

          The Biden administration’s latest efforts to increase transparency into AI tools don’t go far enough to protect patients, the lawmakers said at a Senate Finance Committee hearing.

          advertisement

          Sen. Elizabeth Warren (D-Mass.), citing a STAT investigation, took particularly sharp aim at the use of algorithms to deny care within Medicare Advantage. STAT’s stories had found repeated denials of desperately ill patients by the nation’s largest insurers.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Insmed lung disease drug hits target in key Phase 3 trial
          Insmed lung disease drug hits target in key Phase 3 trial

          AdobeAnexperimentaldrugfromInsmedIncorporatedsuccessfullyreducedlungproblemsamongpatientswithanairwa

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Insmed lung disease drug hits target in key Phase 3 trial

          AdobeAnexperimentaldrugfromInsmedIncorporatedsuccessfullyreducedlungproblemsamongpatientswithanairwa